Diseases, Conditions, Syndromes

Trivalent vaccine candidate fights measles, mumps, SARS-CoV-2

Altered measles and mumps viruses could be used as a platform to create a trivalent COVID-19 vaccine that triggers immunity to multiple variant strains of the SARS-CoV-2 virus, new research in animals suggests.

Medical research

From COVID to cancer: High hopes for Nobel mRNA vaccines

The coronavirus pandemic brought global renown to the mRNA technology that underpins vaccines from Pfizer/BioNTech and Moderna, and on Monday earned a Nobel Prize for two scientists who have been key to its development.

page 1 from 3